MTOR and gestational diabetes: We proposed a mechanism where choline supplementation during maternal obesity and GDM reduced macronutrient anabolism and glucose/fat transport to the fetus by mitigating the mTOR (mechanistic target of rapamycin) signaling pathway in the placenta, leading to reduced fetal overgrowth [4].